In response to the Health Resources & Services Administration (HRSA)’s publication yesterday of ten approved manufacturer plans for its revised 340B rebate pilot program set to take effect Jan. 1, 2027, ACH has issued the following statement: ACH is disgusted that HRSA is moving forward with the ill-advised 340B Rebate Model Pilot Program. Since this […]
Johnson & Johnson will begin requiring 340B-covered entities, including community health centers, to submit claims-level data to maintain access to upfront 340B discounts. The new policy, which takes effect Sept. 15, requires detailed prescription, provider and pharmacy information generally within 45 days of dispensing. Providers that fail to submit timely and complete data could ultimately […]
Johnson & Johnson’s new 340B claims-data policy, effective September 15, will require community health centers and other covered entities to submit extensive claims information whenever a discounted J&J product is dispensed. In an interview with Inside Health Policy, ACH CEO Amanda Pears Kelly warned that the requirement will impose significant administrative and financial burdens on […]
In response to the bipartisan Senate 340B “Gang of Six” working group’s introduction of the SUSTAIN 340B Act on August 5, 2026, Advocates for Community Health (ACH) issued the following statement: “ACH is grateful to Sens. Baldwin (D-WI), Boozman (R-AR), Capito (R-WV), Hickenlooper (D-CO), Kaine (D-VA), and Moran (R-KS) for their leadership to craft comprehensive […]
On July 31, the Health Resources and Services Administration (HRSA) unveiled a new 340B rebate model pilot, triggering immediate reactions across the healthcare sector regarding its potential impact on safety-net providers. The new model which begins January 1, 2027, would change the long-standing program that offers upfront discounts with a new, post-purchase rebate system. While […]
Bloomberg Government reported today that the U.S. Department of Health and Human Services will implement a revised 340B rebate pilot beginning Jan. 1, 2027. The model will require health centers and other covered entities to pay full price for certain drugs and later seek rebates, raising serious concerns about cash-flow disruptions, administrative burdens and the […]
New financial and administrative burdens could force community health centers to reduce services in rural and underserved communities. WASHINGTON — In response to today’s announcement by the U.S. Department of Health and Human Services of a new rebate model for the 340B Drug Pricing Program set to begin on January 1, 2027, Advocates for Community […]
ACH congressional briefing highlighted how 340B savings sustain essential care in rural and underserved communities WASHINGTON — Community health center leaders urged Congress to protect and strengthen the 340B Drug Pricing Program during a congressional briefing hosted Wednesday on Capitol Hill by Advocates for Community Health (ACH), a leading nonpartisan, nonprofit membership organization representing some […]
A new Roll Call article examines the intensifying debate over the future of the 340B Drug Pricing Program as lawmakers consider competing proposals and pharmaceutical manufacturers impose new restriction. ACH CEO Amanda Pears Kelly was interviewed for this story. The article highlights several major developments, including bipartisan legislation from Reps. Scott Peters (D-Calif.) and John […]
Health center leaders will discuss how 340B savings expand access to affordable medications and essential patient services—and how proposed changes could threaten care. WASHINGTON — Advocates for Community Health (ACH), a national nonpartisan, nonprofit organization representing community health centers, will host a congressional briefing, “The 340B Program: A Lifeline for Community Health Centers,” on Wednesday, […]
